tiprankstipranks
PTC Therapeutics (PTCT)
NASDAQ:PTCT
Holding PTCT?
Track your performance easily

PTC Therapeutics (PTCT) Stock Investors

330 Followers
Based on 767,938 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold PTCT
On average, investors allocate 0.00% of their portfolios to PTCT
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 767,938 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding PTCT

6.4%
Last 7
Days
23.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding PTCT, out of 767,938 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

PTCT Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,664 investors who made their portfolios public
The table shows changes in PTCT in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

PTCT Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
4.60%
-1.05%
+5.26%
5.97B
Healthcare
Bristol-Myers Squibb
3.56%
-1.40%
-2.35%
118.65B
Healthcare
Abbott Laboratories
3.53%
+0.10%
+12.15%
199.51B
Healthcare
Block
4.39%
+0.11%
+1.89%
51.33B
Technology
Plug Power
5.23%
-1.16%
-0.55%
1.80B
Industrials
Enphase Energy
4.55%
-0.32%
+3.15%
8.59B
Technology
Trade Desk
4.87%
-0.12%
+3.62%
62.13B
Technology
Merck & Company
3.41%
-0.05%
+4.01%
248.81B
Healthcare
Devon Energy
4.72%
-1.31%
+2.13%
25.87B
Energy
First Solar
4.24%
-0.22%
+4.26%
20.89B
Technology
Based on the activity of 767,938 active portfolios
Open your Smart Portfolio

PTCT Investor Analysis

PTCT investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
11.4%
of PTCT holders
are under 35
Average Segment Performance
Average P/E Ratio26.57
Beta9.43
Dividend Yield51.54%
PTCT investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
45.5%
of PTCT holders
are between 35–55
Average Segment Performance
Average P/E Ratio24.84
Beta18.28
Dividend Yield25.17%
PTCT investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
43.2%
of PTCT holders
are over 55
Average Segment Performance
Average P/E Ratio23.97
Beta8.44
Dividend Yield41.02%
Overview of age group and performance of PTCT stock investors
See who invests in PTCT according to age group and performance.

FAQ

How many retail Investors hold PTCT?
<0.1% of TipRanks' retail investors hold PTCT in their portfolios.
    What is PTCT Investor Sentiment?
    PTCT’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of PTCT in the last 7 days?
      ▲ 6.4% of TipRanks' retail investors changed their holding of PTCT in the last 7 days.
        What percentage of retail investors changed their holding of PTCT in the last 30 days?
        ▲ 23.8% of TipRanks' retail investors changed their holding of PTCT in the last 30 days.
          What is the average age of retail investors who hold PTCT?
          The average age of PTCT Holders is between 35–55.
            What other stocks have PTCT investors also bought?
            PTCT Investors also bought VKTX, BMY, ABT, SQ, PLUG, ENPH, TTD, MRK, DVN, FSLR.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              BAXBaxter International
              BDXBecton Dickinson
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis